Enriching for Tumor-Reactive CD8 TIL with CD39/103 Markers: Implications for TIL Therapy

Publication Title

TIL Therapies Summit

Authors

Andrew D. Weinberg, Earle A. Chiles Research Institute, Providence Cancer InstituteFollow

Document Type

Article

Publication Date

10-20-2021

Keywords

oregon; portland; chiles

Clinical Institute

Cancer

Specialty/Research Institute

Earle A. Chiles Research Institute

Specialty/Research Institute

Oncology